Brentuximab Vedotin

Preferred Label : Brentuximab Vedotin;

MeSH definition : Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA.;

MeSH hyponym : cAC10 vcMMAE; cAC10vcMMAE; CAC10 1006; CAC101006; SGN 35; SGN35;

MeSH Related Number : 914088-09-8;

UNII : 7XL5ISS668;

Details

Origin ID

D000079963;

UMLS CUI

C2973446;

ATC code(s)
- brentuximab vedotin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- brentuximab vedotin [ATC Code]
Currated CISMeF NLP mapping
- Brentuximab Vedotin [NCIt concept]
- Brentuximab vedotin [Substance BNPC]
- Brentuximab vedotin [ICD-11 Extension code]
- Brentuximab vedotin [SMS substance]
- Brentuximab vedotin (substance) [SNOMED CT concept]
- brentuximab vedotin [International Nonproprietary Name]
Pharmacological action(s)
- Antineoplastic Agents, Immunological [MeSH Descriptor]
- immunologic factors [MeSH Descriptor]
- immunotoxins [MeSH Descriptor]
Record concept(s)
- Adcetris [MeSH concept]
- CAC10-1006 [MeSH concept]
- SGN-35 [MeSH concept]
- brentuximab vedotin [MeSH concept]
- cAC10-vcMMAE [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Brentuximab Vedotin [NCIt concept]
- Brentuximab vedotin [Substance BNPC]
- Brentuximab vedotin (substance) [SNOMED CT concept]
- Product containing brentuximab vedotin (medicinal product) [SNOMED CT concept]
- brentuximab vedotin [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients